Calumet (CLMT) Cash & Equivalents (2023 - 2026)

Calumet (CLMT) has 4 years of Cash & Equivalents data on file, last reported at $138.6 million in Q1 2026.

• On a quarterly basis, Cash & Equivalents rose 12.32% year-over-year to $138.6 million in Q1 2026; TTM through Mar 2026 was $138.6 million, a 12.32% increase from a year earlier, with the FY2025 full-year figure at $125.1 million, up 228.35% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $138.6 million, up from $125.1 million in the prior quarter.
• Over the last five years, Cash & Equivalents for CLMT reached as high as $138.6 million in Q1 2026 and fell as low as $7.0 million in Q2 2024.
• Historically, Cash & Equivalents has averaged $63.3 million across 4 years, with a median of $40.4 million in 2023.
• Across the five-year window, Cash & Equivalents tumbled 83.57% in 2024 and surged 1480.0% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $7.9 million in 2023, then jumped by 382.28% to $38.1 million in 2024, then surged by 228.35% to $125.1 million in 2025, then rose by 10.79% to $138.6 million in 2026.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $138.6 million in Q1 2026, $125.1 million in Q4 2025, and $94.6 million in Q3 2025.